By Kim Witczak WoodyMatters On February 12, a joint meeting of the FDA Psychopharmacologic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee endorsed Janssen Pharmaceuticals’ — a division of Johnson & Johnson — experimental nasal spray for depression despite a mixed bag of clinical trial results. The panel voted 14-2 to approve esketamine for major depression in patients who had not benefited despite trying two or more antidepressants. I serve as the consumer representative on the first committee and I was one of the two no votes. This fast-acting nasal spray, esketamine, is a chemical mirror image…

Read More

By Jamie Zimmerman, MD Doctors. When you think of them, what comes to mind? Stethoscopes, white coats, pills?  What if there were a new kind of doctor? One who prescribes meditation, yoga, and other contemplative practices, rather than (or in addition to) doling out medication? More and more doctors are taking an integrative approach in their practices, offering patients alternative therapies to address a multitude of health problems. Here’s how meditation has helped my patients and suggestions on how it might help you. The words meditation and medication sound suspiciously similar, and this is no coincidence.  These words, along with…

Read More